`

Tagged: Biomarker Consulting

BBCR has experience in biologics for rare diseases and can assist with the development of a targeted strategy to meet your study needs.

March 24th, 2021 | Biomarker Consulting

Biologic treatments show promise in providing clinical solutions to a variety of diseases including rare cancers and precision medicine. Services include: Indications analysis and prioritization Strategic drug assessment Clinical study design and protocol Biomarker strategy Early Clinical Development FDA meeting and submission Pre-ND integrated development plan CRO and project management Study remediation and rescue   […]

BBCR Streamlines Clinical Development with the Clinical and Regulatory Expertise to Support Your Development Needs

May 28th, 2020 | Biomarker Consulting

BBCR Consulting offers world-class regulatory, clinical research, and biomarker consulting services that provide high-value, and support our clients’ operational and functional needs. Our process is designed to maximize time efficiencies, risk mitigation, and cost savings. We partner with domestic and international, small-to-medium drug and device companies that are entering early clinical development. BBCR is dedicated […]